by Gertrud U. Rey There are currently 315 therapeutic drugs and 210 vaccine candidates in development to treat or prevent SARS-CoV-2 infection. Many of these vaccines are designed to be administered by injection into the muscle. Intramuscular injection of a vaccine antigen typically induces a systemic (serum) immune response that involves the action of IgM and IgG …
Not only the popular press but even some of my distinguished science colleagues are claiming that the recent report of reinfection of a COVID-19 patient is the end of the world. Nothing could be farther from the truth. First, the facts. The patient is a healthy Hong Kong male who was diagnosed by PCR with …
Immunologist Shane Crotty joins TWiV to discuss the antibody and T cell responses to infection with SARS-CoV-2, followed by answers to listener questions.
In this mid-week episode of Earth’s Virology Podcast, we analyze SARS-CoV-2 transmission among youths at a summer camp, adaptation to mice by passage, the importance of T cells for recovery from COVID-19, and listener questions. Click arrow to playDownload TWiV 650 (73 MB .mp3, 122 min)Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes at microbe.tv/twiv
by Gertrud U. Rey Does a first infection with SARS-CoV-2 make a person immune to a second infection? This question is one of the prevailing issues in the current pandemic. The relevant immune response is adaptive immunity, which initiates during a first exposure to a pathogen and protects from re-infection and disease upon a second …
Hosts: Vincent Racaniello, Rich Condit, and Dickson Despommier Vincent, Dickson, and Rich meant to do an all-email episode, but first they review results of the Blood XMRV Scientific Research Working Group, and partial retraction of the paper associating XMRV with chronic fatigue syndrome. With this episode TWiV is three years old. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV150.mp3″] Click the arrow above …
